Ibalgin Express

Ibuprofen, the active ingredient in Ibalgin Express, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It provides analgesic, antipyretic and anti‑inflammatory effects for the relief of mild to moderate pain, fever and inflammatory conditions in adults and, where appropriate, children.

GNH USA supplies Ibalgin Express as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from regulatory compliance and traceability throughout the supply chain.

Ibuprofen acts systemically to reduce prostaglandin‑mediated inflammation and is commonly employed for several acute and chronic conditions.

- Pain: alleviates mild to moderate acute pain such as headache, dental pain, or musculoskeletal discomfort. - Fever: lowers elevated body temperature associated with viral or bacterial infections. - Osteoarthritis: reduces joint pain and improves functional mobility in degenerative joint disease. - Rheumatoid arthritis: helps control inflammatory joint pain and swelling in autoimmune arthritis. - Dysmenorrhea: eases menstrual cramps and associated pelvic pain.

Ibuprofen may cause a range of adverse reactions, varying from mild and frequent to rare but serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate tension‑type headache. - Dizziness: transient light‑headedness. - Rash: mild skin erythema or itching. - Elevated blood pressure: small increases in hypertensive patients.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: potentially life‑threatening hemorrhage. - Renal impairment: acute kidney injury, especially with dehydration. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome. - Cardiovascular events: increased risk of myocardial infarction or stroke.

When using ibuprofen, several safety considerations should be observed to minimise risk.

- Assess renal function: avoid use in patients with severe renal impairment or dehydration. - Monitor gastrointestinal risk: consider gastro‑protective agents in those with history of ulcers or bleeding. - Evaluate cardiovascular status: use cautiously in individuals with hypertension, heart failure or prior thrombotic events. - Review concomitant medications: avoid concurrent use with other NSAIDs, anticoagulants or corticosteroids without medical supervision. - Pregnancy and lactation: consult a healthcare professional before use during pregnancy or breastfeeding. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ibuprofen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding risk. - Lithium: ibuprofen may raise lithium serum concentrations, risking toxicity. - Methotrexate (high‑dose): reduced renal clearance leading to toxicity. - ACE inhibitors or ARBs: may diminish antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in antihypertensive response. - Corticosteroids: additive risk of gastrointestinal ulceration. - Antihypertensives (beta‑blockers): monitor blood pressure control. - Oral hypoglycemics: ibuprofen may affect glucose control. - Anticonvulsants (e.g., phenytoin): may alter plasma levels.